Sign In
Buy LABU
$165.45
+7.29 (+4.61%)
At Close: Jun 03, 2026
LABU Provides Leveraged Access For Risk-Taking Investors
07:38am, Monday, 27'th Sep 2021
LABU Provides Leveraged Access For Risk-Taking Investors
ETF/ETN Breakouts Week 39 - September 2021: Short-Term Funds To Give You An Edge
04:08pm, Sunday, 26'th Sep 2021
This is the first public release of the weekly ETF/ETN forecast article, highlighting some strong sectors, index funds and commodities for your consideration. This report goes out weekly with live dai
7 Best Leveraged ETF Areas of Last Week
09:08am, Monday, 30'th Aug 2021
Wall Street was upbeat last week. News of zero new cases in China, U.S. FDA's full approval of Pfizer-BioNTech Covid-19 vaccine and no new flare-up in taper talks led to the gains.
Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs
12:14pm, Thursday, 26'th Aug 2021
Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.
5 Best Inverse/Leveraged ETF Areas of Last Week
02:39pm, Monday, 09'th Aug 2021
Last week was upbeat for Wall Street. Stocks basically ignored myriad of concerns including inflationary pressures and rising Delta variant of COVID-19 cases.
ARK: Cathie Wood And The Exquisite Art Of Tail Gunning
10:47am, Monday, 14'th Jun 2021
ARK Active ETFs are worth the management fee. Structured Lookback is introduced.
5 Best Leveraged ETFs of Last Week
09:47am, Monday, 14'th Jun 2021
We highlight a few leveraged ETF areas that won last week.
A Biotech ETF For Aggressive, Risk-Tolerant Investors
01:05pm, Tuesday, 08'th Jun 2021
The biotechnology sector has been on fire thanks to news from Biogen Inc. (NASDAQ: BIIB). The FDA approved its controverisal drug that can treat Alzheimer's Disease.
Best Leveraged ETF Areas of Last Week
09:01am, Monday, 26'th Apr 2021
Last week was slightly downbeat for Wall Street on talks of a capital gain tax hike.
Biotech Innovations Remain At Forefront
11:10am, Friday, 16'th Apr 2021
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r
Moving Beyond COVID In Biopharma
09:31am, Thursday, 15'th Apr 2021
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,
These 3 Popular ETFs Are Geared Toward Tactical Plays
08:19am, Wednesday, 14'th Apr 2021
Direxion's weekly ETF fund flows could shed light on what traders are thinking. The top three point to interest in long-term bond prices, biotech strength, and semiconductor weakness.
Biden's Infrastructure Can Put These 2 Leveraged Funds in Play
01:46pm, Friday, 09'th Apr 2021
U.S. president Joe Biden's infrastructure plan is opening up ETF trading possibilities from multiple angles. One way is playing its healthcare component via funds like the Direxion Daily Healthcare Bu
6 Top Leveraged ETF Areas of Last Week
01:14pm, Monday, 15'th Mar 2021
The S&P 500, the Dow Jones, the Nasdaq Composite and the small-cap Russell 2000 were all on an uptrend last week.
Leveraged ETFs In the Pink After 1 Year of Pandemic
12:28pm, Monday, 15'th Mar 2021
Investors flocked to leveraged ETFs to cash in on the opportunity offered by an improving economy and a rising stock market.
